# Rare Element Resources Ltd: Form 10-Q for the period ended Jun 30, 2022

- Company: [Rare Element Resources Ltd](/companies/reemf.md) (CIK 1419806)
- Form: 10-Q
- Filed: 2022-08-10
- Accepted by EDGAR: Aug 10, 2022, 13:11 ET
- Period: 2022-06-30
- Accession: 0001419806-22-000023
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1419806/000141980622000023/reemf-20220630x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1419806/000141980622000023/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Net income | 3 months, 2022-04-01 to 2022-06-30 | −$2.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2022-01-01 to 2022-06-30 | −$4.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-04-01 to 2022-06-30 | −$0.01 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2022-01-01 to 2022-06-30 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-04-01 to 2022-06-30 | −$0.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2022-01-01 to 2022-06-30 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-04-01 to 2022-06-30 | 212,466,889 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2022-01-01 to 2022-06-30 | 212,466,889 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2022-01-01 to 2022-06-30 | −$4.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2022-06-30 | $21.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-06-30 | $21.8m | us-gaap:AssetsCurrent |
| Total assets | at 2022-06-30 | $22.7m | us-gaap:Assets |
| Current liabilities | at 2022-06-30 | $578.0k | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-06-30 | $2.1m | us-gaap:Liabilities |
| Shareholders' equity | at 2022-06-30 | $20.6m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 9,881 characters.

The following management’s discussion and analysis of the consolidated financial results and condition of Rare Element Resources Ltd. (collectively, “we,” “us,” “our,” “Rare Element” or the “Company”) for the three months ended June 30, 2022, has been prepared based on information available to us as of August 10, 2022. This discussion should be read in conjunction with the unaudited Condensed Consolidated Financial Statements and notes thereto included herewith and the audited Consolidated Financial Statements of Rare Element for the year ended December 31, 2021, and the related notes thereto filed with our Annual Report on Form 10-K, which have been prepared in accordance with U.S. GAAP. This discussion and analysis contains forward-looking statements that involve risks, uncertainties, and assumptions. Our actual results, performance, or achievements may differ materially from those anticipated in these forward-looking statements as a result of many factors, including, but not limited to, those set forth elsewhere in this report. See “Cautionary Note Regarding Forward-Looking Statements.”

***All currency amounts are expressed in thousands of U.S. dollars, unless otherwise noted.***

### Outlook

During the six months ended June 30, 2022, the Company continued its work on the demonstration plant (the “Demonstration Plant”) project, and this work is expected to continue over the remainder of 2022 and through the project’s expected completion date in the early part of 2025. Key Demonstration Plant project activities over the next six months are expected to include completion of final plant design, continuation of licensing and permitting efforts, and procurement of long lead-time equipment. Originally scheduled for later in the Demonstration Plant project’s timeline, the procurement of certain long-lead equipment has been moved earlier in the schedule due to price inflation and supply chain concerns. This scheduling change has, in turn, necessitated a contract modification with the DoE. This modification is currently being negotiated between General Atomics and the DoE and is expected to be complete in the fourth quarter of 2022. While not expected to impact the Demonstration Plant project’s overall timeline of 40 months, the modification is expected to adjust the DoE’s first project continuation decision point from October 2022 to May 2023 to coincide with the completion of the U.S. Nuclear Regulatory Commission licensing process. Over the next six months, the Company also plans to update its baseline environmental data for the Bear Lodge REE Project.

Longer term, the Company does not have sufficient funds to progress with activities beyond the Demonstration Plant project, including feasibility studies, permitting and licensing, development and construction related to its Bear Lodge REE Project. Therefore, the achievement of these longer-term activities will be dependent upon receipt of additional funds through financings, off-take agreements, joint ventures, strategic transactions, or sales of various assets. There is no assurance, however, that the Company will be successful in completing any such other financings or transactions. Ultimately, in the event the Company cannot secure additional financial resources, or complete a strategic transaction in the longer term, it may need to suspend its operational plans or even have to liquidate its business interests, and investors may lose all or part of their investment.

#### COVID-19 Impact on Business

In response to the COVID-19 pandemic, we implemented travel restrictions, both domestically and internationally, and our employee and consultants abided by government guidance and orders. As a result, we saw delays in the metallurgical studies conducted by UIT that slowed the progression of prior test work. Any continued pandemic impact may be material to the completion of the design inputs needed for the Demonstration Plant. Any further economic downturn triggered by COVID-19 and any resulting direct and indirect negative impact on us could have a material adverse impact on our future activities, cash flows and liquidity. We are seeing higher prices for the equipment and raw materials for the Demonstration Plant due to shortages, commodity inflation and supply chain issues, including transportation delays as a result of COVID-19 and other economic factors. Further, it is unknown what, if any, impact COVID-19 and any resulting economic factors will have on rare earth prices and market supply and demand fundamentals. For further discussion of this matter, refer to “Item 1A. Risk Factors” in Part II of the Company’s Annual Report on Form 10-K as filed on March 23, 2022.

### Results of Operations

### Summary

For the three-and six-month periods ended June 30, 2022, we experienced net losses of $2,626 ($0.01 per share) and $4,822 ($0.02 per share), respectively, compared with net losses of $1,266 ($0.01 per share) and 2,314 ($0.01 per share) for the three-and six-month periods ended June 30, 2021, respectively. See our discussion below for the primary drivers of these changes.

### Exploration and evaluation

Our exploration and evaluation costs increased by $450 over the comparative three-month period, rising from $417 for the three months ended June 30, 2021 to $867 for the three months ended June 30, 2022, and by $573 over the comparative six-month period, rising from $924 for the six months ended June 30, 2021 to $1,497 for the six months ended June 30, 2022. These increases were largely attributable to the activities associated with our Bear Lodge REE Project and the Demonstration Plant as work progressed under the Cost Share Agreement. See Note 4 to the Condensed Consolidated Financial Statements for a more complete discussion of this Cost Share Agreement.

### Corporate administration

Our corporate administrative costs increased by $849 over the comparative three-month period rising from $828 for the three months ended June 30, 2021 to $1,677 for the three months ended June 30, 2022, and by $1,799 over the comparative six-month period rising from $1,348 for six months ended June 30, 2021 to $3,147 for six months ended June 30, 2022. These increases were largely driven by the increases in our stock-based compensation of $581 and $1,503 over the comparative three and six-month periods, respectively, and our accrual for Mr. Scott’s severance payment of $242 during the three months ended June 30, 2022.

### Accretion expense

The Company’s accretion expense increased by $51 over the comparative three-month period, rising from $20 for the three months ended June 30, 2021 to $71 for the three months ended June 30, 2022, and by $102 over the comparative six-month period, rising from $40 for the six months ended June 30, 2021 to $142 for the six months ended June 30, 2022. This accretion expense is related to the Company’s option to repurchase approximately 640 acres of non-core real property in Wyoming for not less than $1,200 or greater than $1,850 in the form of cash, common shares of the Company, or a combination of cash and common shares of the Company. Accretion expense is recorded each reporting period to increase the repurchase option liability to the maximum exercise price of $1,850, less any annual option payments of $25. See Note 7 to the Condensed Consolidated Financial Statements for a more complete discussion of the repurchase option.

### Cash Flows, Financial Position, Liquidity and Capital Resources

#### Cash Flows from Operating Activities

Net cash used in operating activities was $3,969 for the six months ended June 30, 2022, compared with $1,284 for the same period in 2021. This increase of $2,685 was mostly driven by an increase in prepaid expenses of $562 related to the Company’s prepayment of funds to General Atomics under the Cost Share Agreement and a decrease in accounts payable and accrued liabilities of $1,189 largely stemming from the payment of a $712 amount owing to General Atomics, a related party, during the six months ended June 30, 2022.

#### Financial Position, Liquidity and Capital Resources

At June 30, 2022, we had a working capital balance of $21,217 which represented a decrease of $2,668 to our December 31, 2021 working capital balance of $23,885. This decrease was largely the result of amounts paid by the Company during the six months ended June 30, 2022 under the Cost Share Agreement.

Inclusive of amounts already advanced, the Company’s share of the total cost under the Cost Share Agreement are expected to equal or exceed $22,000 over the life of the project. As a result, the Company will not have sufficient funds to progress with longer-term activities, including feasibility studies, permitting, development and construction related to the Bear Lodge REE Project. Therefore, the achievement of these longer-term activities will be dependent upon additional financings, off-take agreements, joint ventures, strategic transactions, or sales of various assets. There is no assurance, however, that the Company will be successful in completing any such financings or other transactions. Ultimately, in the event the Company cannot secure additional financial resources, or complete a strategic transaction in the longer term, it may need to suspend its operational plans or even have to liquidate its business interests, and investors may lose all or part of their investment.

### Contractual Obligations

During June 2022, the Company entered into an amendment to its employment agreement with Randall J. Scott, the Company’s Chief Executive Officer. See Note 7 to the condensed consolidated financial statements for the period ended June 30, 2022 for a complete discussion. There were no other material changes to the contractual obligations disclosed in Item 8 of Part II of our Annual Report on Form 10-K for the year ended December 31, 2021.

## Controls and procedures

As filed, 1,410 characters.

### Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation was carried out under the supervision of, and with the participation of the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of the design and operations of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on that evaluation, the CEO and the CFO have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were effective in ensuring that (i) information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

### Changes in Internal Controls

There has been no change in our internal control over financial reporting during the quarter ended June 30, 2022, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 196 characters.

During the six months ended June 30, 2022, there were no material changes to the risk factors disclosed in Item 1A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2021.

Filed Aug 10, 2022.
Source: SEC EDGAR, the filing index for accession 0001419806-22-000023. Last ingested by Listed: Nov 4, 2026, 15:46 ET. No prices; not investment advice.
